Number of the records: 1  

Implant-forming polymeric 19F MRI-tracer with tunable dissolution

  1. 1.
    SYSNO ASEP0531585
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleImplant-forming polymeric 19F MRI-tracer with tunable dissolution
    Author(s) Kolouchová, Kristýna (UMCH-V) ORCID, RID
    Jirák, D. (CZ)
    Groborz, Ondřej (UMCH-V) ORCID, RID
    Sedlacek, O. (BE)
    Ziolkowska, N. (CZ)
    Vít, M. (CZ)
    Sticová, E. (CZ)
    Gálisová, A. (CZ)
    Švec, Pavel (UMCH-V) RID, ORCID
    Trousil, Jiří (UMCH-V) RID, ORCID
    Hajek, M. (CZ)
    Hrubý, Martin (UMCH-V) RID, ORCID
    Source TitleJournal of Controlled Release. - : Elsevier - ISSN 0168-3659
    Roč. 327, 10 November (2020), s. 50-60
    Number of pages11 s.
    Languageeng - English
    CountryNL - Netherlands
    Keywordspolymer implant ; 19F magnetic resonance imaging ; double-stimuli responsivity
    Subject RIVCD - Macromolecular Chemistry
    OECD categoryPolymer science
    R&D ProjectsLTC19032 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    LO1507 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    GA18-07983S GA ČR - Czech Science Foundation (CSF)
    Method of publishingLimited access
    Institutional supportUMCH-V - RVO:61389013
    UT WOS000585933700006
    EID SCOPUS85089267901
    DOI10.1016/j.jconrel.2020.07.026
    AnnotationMagnetic resonance imaging (MRI) using 19F-based tracers has emerged as a promising multi-purpose noninvasive diagnostic tool and its application requires the use of various 19F-based tracers for the intended diagnostic purpose. In this study, we report a series of double-stimuli-responsive polymers for use as injectable implants, which were designed to form implants under physiological conditions, and to subsequently dissolve with different dissolution rates (t1/2 ranges from 30 to more than 250 days). Our polymers contain a high concentration of fluorine atoms, providing remarkable signal detectability, and both a hydrophilic monomer and a pH-responsive monomer that alter the biodistribution properties of the implant. The implant location and dissolution were observed using 19F MRI, which allows the anatomic extent of the implant to be monitored. The dissolution kinetics and biocompatibility of these materials were thoroughly analyzed. No sign of toxicity in vitro or in vivo or pathology in vivo was observed, even in chronic administration. The clinical applicability of our polymers was further confirmed via imaging of a rat model by employing an instrument currently used in human medicine.
    WorkplaceInstitute of Macromolecular Chemistry
    ContactEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Year of Publishing2021
    Electronic addresshttps://www.sciencedirect.com/science/article/pii/S0168365920304107?via%3Dihub
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.